Novel pathologic findings in patients with Pelizaeus-Merzbacher disease

Neuroscience Letters

Volumn 627, Issue , 2016, Pages 222-232

  Laukka, Jeremy J ^a   Kamholz, John ^b,c   Bessert, Denise ^b   Skoff, Robert P ^b  

^a MEDICAL COLLEGE OF OHIO   (United States)

^b WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF IOWA   (United States)

Author keywords

Electron microscopy; Hypomyelination; Immunocytochemistry; Myelin and axon pathology; Pelizaeus Merzbacher disease; Proteolipid protein

Indexed keywords

MYELIN; PROTEOLIPID PROTEIN; PROTEOLIPID PROTEIN 1; UNCLASSIFIED DRUG; PLP1 PROTEIN, HUMAN;

ARTICLE; ASTROCYTOSIS; AUTOPSY; AXOPLASM; BRAIN TISSUE; CORPUS CALLOSUM; GAIN OF FUNCTION MUTATION; GENE DELETION; GENE DUPLICATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; LOSS OF FUNCTION MUTATION; MICROTUBULE; MYELIN SHEATH; MYELINATION; NERVE CELL DEGENERATION; NEUROFILAMENT; NEUROPIL; OLIGODENDROGLIA; PELIZAEUS MERZBACHER DISEASE; PRIORITY JOURNAL; AXON; BRAIN; GENETICS; MALE; MIDDLE AGED; MUTATION; PATHOLOGY; ULTRASTRUCTURE;

AXONS; CEREBRUM; CORPUS CALLOSUM; GENE DELETION; GENE DUPLICATION; HUMANS; MALE; MIDDLE AGED; MUTATION; MYELIN PROTEOLIPID PROTEIN; MYELIN SHEATH; PELIZAEUS-MERZBACHER DISEASE;

EID: 84976433776     PISSN: 03043940     EISSN: 18727972     Source Type: Journal    
DOI: 10.1016/j.neulet.2016.05.028     Document Type: Article

References (68)

1. Albert M., Antel J., Bruck W., Stadelmann C. Extensive cortical remyelination in patients with chronic multiple sclerosis. Brain Pathol. 2007, 17:129-138.
2. Appikatla S., Bessert D., Lee I., Huttemann M., Mullins C., Somayajulu-Nitu M., Yao F., Skoff R.P. Insertion of proteolipid protein into oligodendrocyte mitochondria regulates extracellular pH and adenosine triphosphate. Glia 2014, 62:356-373.
3. Arnold D.L., Riess G.T., Matthews P.M., Francis G.S., Collins D.L., Wolfson C., Antel J.P. Use of proton magnetic resonance spectroscopy for monitoring disease progression in multiple sclerosis. Ann. Neurol. 1994, 36:76-82.
4. Baechner D., Liehr T., Hameister H., Altenberger H., Grehl H., Suter U., Rautenstrauss B. Widespread expression of the peripheral myelin protein-22 gene (PMP22) in neural and non-neural tissues during murine development. J. Neurosci. Res. 1995, 42:733-741.
5. Bizzozero O.A., Bixler H.A., Davis J.D., Espinosa A., Messier A.M. Chemical deacylation reduces the adhesive properties of proteolipid protein and leads to decompaction of the myelin sheath. J. Neurochem. 2001, 76:1129-1141.
6. Bjartmar C., Wujek J.R., Trapp B.D. Axonal loss in the pathology of MS: consequences for understanding the progressive phase of the disease. J. Neurol. Sci. 2003, 206:165-171.
7. Boison D., Bussow H., D'Urso D., Muller H.W., Stoffel W. Adhesive properties of proteolipid protein are responsible for the compaction of CNS myelin sheaths. J. Neurosci. 1995, 15:5502-5513.
8. Boison D., Stoffel W. Disruption of the compacted myelin sheath of axons of the central nervous system in proteolipid protein-deficient mice. Proc. Natl. Acad. Sci. U. S. A. 1994, 91:11709-11713.
9. Cerghet M., Bessert D.A., Nave K.A., Skoff R.P. Differential expression of apoptotic markers in jimpy and in Plp overexpressors: evidence for different apoptotic pathways. J. Neurocytol. 2001, 30:841-855.
10. Clark K., Sakowski L., Sperle K., Banser L., Landel C.P., Bessert D.A., Skoff R.P., Hobson G.M. Gait abnormalities and progressive myelin degeneration in a new murine model of Pelizaeus-Merzbacher disease with tandem genomic duplication. J. Neurosci. 2013, 33:11788-11799.
11. De Stefano N., Matthews P.M., Fu L., Narayanan S., Stanley J., Francis G.S., Antel J.P., Arnold D.L. Axonal damage correlates with disability in patients with relapsing- remitting multiple sclerosis. Results of a longitudinal magnetic resonance spectroscopy study. Brain: J. Neurol. 1998, 121:1469-1477.
12. De Stefano N., Matthews P.M., Narayanan S., Francis G.S., Antel J.P., Arnold D.L. Axonal dysfunction and disability in a relapse of multiple sclerosis: longitudinal study of a patient. Neurology 1997, 49:1138-1141.
13. Duncan I.D., Hammang J.P., Goda S., Quarles R.H. Myelination in the jimpy mouse in the absence of proteolipid protein. Glia 1989, 2:148-154.
14. Dyakin V.V., Chen Y., Branch C.A., Veeranna, Yuan A., Rao M., Kumar A., Peterhoff C.M., Nixon R.A. The contributions of myelin and axonal caliber to transverse relaxation time in shiverer and neurofilament-deficient mouse models. Neuroimage 2010, 51:1098-1105.
15. Foote A.K., Blakemore W.F. Inflammation stimulates remyelination in areas of chronic demyelination. Brain: J. Neurol. 2005, 128:528-539.
16. Fu L., Matthews P.M., De Stefano N., Worsley K.J., Narayanan S., Francis G.S., Antel J.P., Wolfson C., Arnold D.L. Imaging axonal damage of normal-appearing white matter in multiple sclerosis. Brain: J. Neurol. 1998, 121:103-113.
17. Fyffe-Maricich S.L., Schott A., Karl M., Krasno J., Miller R.H. Signaling through ERK1/2 controls myelin thickness during myelin repair in the adult central nervous system. J. Neurosci. 2013, 33:18402-18408.
18. Garbern J.Y., Cambi F., Lewis R., Shy M., Sima A., Kraft G., Vallat J.M., Bosch E.P., Hodes M.E., Dlouhy S., Raskind W., Bird T., Macklin W., Kamholz J. Peripheral neuropathy caused by proteolipid protein gene mutations. Ann. N. Y. Acad. Sci. 1999, 883:351-365.
19. Garbern J.Y., Yool D.A., Moore G.J., Wilds I.B., Faulk M.W., Klugmann M., Nave K.A., Sistermans E.A., van der Knaap M.S., Bird T.D., Shy M.E., Kamholz J.A., Griffiths I.R. Patients lacking the major CNS myelin protein proteolipid protein 1, develop length-dependent axonal degeneration in the absence of demyelination and inflammation. Brain: J. Neurol. 2002, 125:551-561.
20. Gonen O., Catalaa I., Babb J.S., Ge Y., Mannon L.J., Kolson D.L., Grossman R.I. Total brain N-acetylaspartate: a new measure of disease load in MS. Neurology 2000, 54:15-19.
21. Gow A., Southwood C.M., Lazzarini R.A. Disrupted proteolipid protein trafficking results in oligodendrocyte apoptosis in an animal model of Pelizaeus-Merzbacher disease. J. Cell Biol. 1998, 140:925-934.
22. Harding B., Ellis D., Malcolm S. A case of Pelizaeus-Merzbacher disease showing increased dosage of the proteolipid protein gene. Neuropathol. Appl. Neurobiol. 1995, 21:111-115.
23. Hartman B.K., Agrawal H.C., Agrawal D., Kalmbach S. Development and maturation of central nervous system myelin: comparison of immunohistochemical localization of proteolipid protein and basic protein in myelin and oligodendrocytes. Proc. Natl. Acad. Sci. U. S. A 1982, 79:4217-4220.
24. Hobson G.M., Huang Z., Sperle K., Stabley D.L., Marks H.G., Cambi F. A PLP splicing abnormality is associated with an unusual presentation of PMD. Ann. Neurol. 2002, 52:477-488.
25. Inoue K., Osaka H., Imaizumi K., Nezu A., Takanashi J., Arii J., Murayama K., Ono J., Kikawa Y., Mito T., Shaffer L.G., Lupski J.R. Proteolipid protein gene duplications causing Pelizaeus-Merzbacher disease: molecular mechanism and phenotypic manifestations. Ann. Neurol. 1999, 45:624-632.
26. Inoue K., Osaka H., Sugiyama N., Kawanishi C., Onishi H., Nezu A., Kimura K., Kimura S., Yamada Y., Kosaka K. A duplicated PLP gene causing Pelizaeus-Merzbacher disease detected by comparative multiplex PCR. Am. J. Hum. Genet. 1996, 59:32-39.
27. Iyoda K., Tanaka J., Suzuki Y., Nagao Y., Ohtahara S. Histopathologic and biochemical analysis of classic Pelizaeus- Merzbacher disease. Pediatr. Neurol. 1988, 4:252-254.
28. Jarjour A.A., Boyd A., Dow L.E., Holloway R.K., Goebbels S., Humbert P.O., Williams A., ffrench-Constant C. The polarity protein Scribble regulates myelination and remyelination in the central nervous system. PLoS Biol. 2015, 13:e1002107.
29. Klugmann M., Schwab M.H., Pühlhofer A., Schneider A., Zimmermann F., Griffiths I.R., Nave K.-A. Assembly of CNS myelin in the absence of proteolipid protein. Neuron 1997, 18:59-70.
30. Konishi Y., Kamoshita S. An autopsy case of classical Pelizaeus-Merzbacher's disease. Acta Neuropathol. 1975, 31:267-270.
31. Laukka J.J., Makki M.I., Lafleur T., Stanley J., Kamholz J., Garbern J.Y. Diffusion tensor imaging of patients with proteolipid protein 1 gene mutations. J. Neurosci. Res. 2014, 92:1723-1732.
32. Merzbacher L. Eine eigenarige familiär-hereditare Erkrankungsform (Aplasia axialis extra-corticalis congenita). Zeitschrift für gesamte Neurologie und Psychiatrie 1910, 3:1-138.
33. Mimault C., Giraud G., Courtois V., Cailloux F., Boire J.Y., Dastugue B., Boespflug-Tanguy O. Proteolipoprotein gene analysis in 82 patients with sporadic Pelizaeus- Merzbacher disease: duplications the major cause of the disease, originate more frequently in male germ cells, but point mutations do not. The clinical European network on brain dysmyelinating disease. Am. J. Hum. Genet. 1999, 65:360-369.
34. Nagao M., Kadowaki J. Connatal Pelizaeus-Merzbacher disease: a missense mutation in exon 4 of the proteolipid protein (PLP) gene. J. Hum. Genet. 1998, 43:206-208.
35. Narayanan S.P., Flores A.I., Wang F., Macklin W.B. Akt signals through the mammalian target of rapamycin pathway to regulate CNS myelination. J. Neurosci. 2009, 29:6860-6870.
36. Nave K.A., Milner R.J. Proteolipid proteins: structure and genetic expression in normal and myelin-deficient mutant mice. Crit. Rev. Neurobiol. 1989, 5:65-91.
37. Pelizaeus F. Über eine eigenthümliche form spastischer Lähmung mit cerebralerschinungen auf hereditärer grundlage (Multiple sklerose). Arch. Psychiatr. Nervenkr. 1885, 16:698-710.
38. Pham-Dinh D., Boespflug-Tanguy O., Mimault C., Cavagna A., Giraud G., Leberre G., Lemarec B., Dautigny A. Pelizaeus-Merzbacher disease: a frameshift deletion/insertion event in the myelin proteolipid gene. Hum. Mol. Genet. 1993, 2:465-467.
39. Pierson C.R., Garbern J., Golden J.A., Kupsky W., Sima A.A. Neuronal system degeneration in Pelizaeus-Merzbacher disease with PLP1 gene duplication. J. Neuropathol. Exp. Neurol. 2002, 61:34.
40. Raskind W.H., Williams C.A., Hudson L.D., Bird T.D. Complete deletion of the proteolipid protein gene (PLP) in a family with X-linked Pelizaeus-Merzbacher disease. Am. J. Hum. Genet. 1991, 49:1355-1360.
41. Rosenbluth J., Nave K.A., Mierzwa A., Schiff R. Subtle myelin defects in PLP-null mice. Glia 2006, 54:172-182.
42. Rosenbluth J., Stoffel W., Schiff R. Myelin structure in proteolipid protein (PLP)-null mouse spinal cord. J. Comp. Neurol. 1996, 371:336-344.
43. Sachs H.H., Bercury K.K., Popescu D.C., Narayanan S.P., Macklin W.B. A new model of cuprizone-mediated demyelination/remyelination. ASN Neuro 2014, 6.
44. Saugier-Veber P., Munnich A., Bonneau D., Rozet J.M., Le Merrer M., Gil R., Boespflug-Tanguy O. X-linked spastic paraplegia and Pelizaeus-Merzbacher disease are allelic disorders at the proteolipid protein locus. Nat. Genet. 1994, 6:257-262.
45. Seitelberger F. Neuropathology and genetics of Pelizaeus-Merzbacher disease. Brain Pathol. 1995, 5:267-273.
46. Seitelberger F. Pelizaeus-Merzbacher disease. Handbook of Clinical Neurology 1970, vol. 10:150-220. North Holland Publishing Co., Amsterdam.
47. Seitelberger F. Structural manifestations of leukodystrophies. Neuropediatrics 1984, 15:53-61.
48. Sima A.A., Pierson C.R., Woltjer R.L., Hobson G.M., Golden J.A., Kupsky W.J., Schauer G.M., Bird T.D., Skoff R.P., Garbern J.Y. Neuronal loss in Pelizaeus-Merzbacher disease differs in various mutations of the proteolipid protein 1. Acta Neuropathol. 2009, 118:531-539.
49. Sistermans E.A., de Coo R.F., de Wijs I.J., van Oost B.A. Duplication of the proteolipid protein gene is the major cause of Pelizaeus-Merzbacher disease. Neurology 1998, 50:1749-1754.
50. Southwood C.M., Garbern J., Jiang W., Gow A. The unfolded protein response modulates disease severity in Pelizaeus-Merzbacher Disease. Neuron 2002, 36:585-596.
51. Steenweg M.E., Vanderver A., Blaser S., Bizzi A., de Koning T.J., Mancini G.M., van Wieringen W.N., Barkhof F., Wolf N.I., van der Knaap M.S. Magnetic resonance imaging pattern recognition in hypomyelinating disorders. Brain: J. Neurol. 2016, 133:2971-2982.
52. Tatar C.L., Appikatla S., Bessert D.A., Paintlia A.S., Singh I., Skoff R.P. Increased Plp1 gene expression leads to massive microglial cell activation and inflammation throughout the brain. ASN Neuro 2010, 2:e00043.
53. Thurston V.C., Gobbett T.A., Smith L.R., Gao Q., Inoue K., Lupski J.R., Dlouhy S.R., Clarke J.T.R., Hodes M.E., Vance G.H. Deletion of the proteolipid protein gene (PLP) in a patient with Pelizaeus-Merzbacher disease. Am. J. Hum. Genet. 2001, 69:871.
54. Torii T., Miyamoto Y., Yamauchi J., Tanoue A. Pelizaeus-Merzbacher disease: cellular pathogenesis and pharmacologic therapy. Pediatr. Int. 2014, 56:659-666.
55. Torisu H., Iwaki A., Takeshita K., Hiwatashi A., Sanefuji M., Fukumaki Y., Hara T. Clinical and genetic characterization of a 2-year-old boy with complete PLP1 deletion. Brain Dev. 2012, 34:852-856.
56. Trapp B.D., Peterson J., Ransohoff R.M., Rudick R., Mork S., Bo L. Axonal transection in the lesions of multiple sclerosis. N. Engl. J. Med. 1998, 338:278-285.
57. Trapp B.D., Ransohoff R., Rudick R. Axonal pathology in multiple sclerosis: relationship to neurologic disability. Curr. Opin. Neurol. 1999, 12:295-302.
58. Trofatter J.A., Dlouhy S.R., DeMyer W., Conneally P.M., Hodes M.E. Pelizaeus-Merzbacher disease: tight linkage to proteolipid protein gene exon variant. Proc. Natl. Acad. Sci. U.S.A. 1989, 86:9427-9430.
59. Ulrich J., Herschkowitz N. Seitelberger's connatal form of Pelizaeus-Merzbacher disease. Case report clinical, pathological and biochemical findings. Acta Neuropathol. 1977, 40:129-136.
60. Vuia O. Congenital Pelizaeus-Merzbacher disease (Seitelberger type), malformation and cystic degeneration of the central nervous system. Neuropadiatrie 1978, 9:172-184.
61. Watanabe I., McCaman R., Dyken P., Zeman W. Absence of cerebral myelin sheaths in a case of presumed Pelizaeus-Merzbacher disease. Electron microscopic and biochemical studies. J. Neuropathol. Exp. Neurol. 1969, 28:243-256.
62. Waxman S.G. Conduction in myelinated, unmyelinated, and demyelinated fibers. Arch. Neurol. 1977, 34:585-589.
63. Wolf N.I., Sistermans E.A., Cundall M., Hobson G.M., Davis-Williams A.P., Palmer R., Stubbs P., Davies S., Endziniene M., Wu Y., Chong W.K., Malcolm S., Surtees R., Garbern J.Y., Woodward K.J. Three or more copies of the proteolipid protein gene PLP1 cause severe Pelizaeus-Merzbacher disease. Brain: J. Neurol. 2005, 128:743-751.
64. Woodward K., Kendall E., Vetrie D., Palmer R., Dlouhy S.R., Hodes M.E., Malcolm S. Variation in PLP gene duplications causing Pelizaeus-Merzbacher disease. Am. J. Hum. Genet. 1998, 63:A394.
65. Woodward K.J. The molecular and cellular defects underlying Pelizaeus-Merzbacher disease. Expert Rev. Mol. Med. 2008, 10:e14.
66. msd mouse mutation and connatal pelizaeus-Merzbacher disease. Am. J. Med. Genet. 1998, 75:439-440.
67. Zeman W., DeMyer W., Falls H.F. Pelizaeus-Merzbacher disease: a study in nosology. J. Neuropathol. Exp. Neurol. 1964, 23:334-354.
68. Watanabe I., Patel V., Goebel H.H., Siakotos A.N., Zeman W., DeMyer W., Dyer J.S. Early lesion of Pelizaeus-Merzbacher disease: electron microscopic and biochemical study. J. Neuropathol. Exp. Neurol. 1973, 32(April (2)):313-333.